Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
After-Hours: 20:00
Marker Therapeutics Shareholders Equity (Quarterly): 18.39M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 431.19M |
| Viridian Therapeutics, Inc. | 502.97M |
| Neurocrine Biosciences, Inc. | 3.004B |
| Kiniksa Pharmaceuticals International Plc | 535.38M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.73M |
| Total Liabilities (Quarterly) | 3.346M |
| Current Ratio | 6.496 |